Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Li Gobbi

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Antibodies (Basel, Switzerland)|March 24, 2026
Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel ObservationMaurizio Benucci, Elisa Cioffi, Francesca Li Gobbi, et al.
Journal of Clinical Medicine|June 27, 2024
Do Ultrasound Lung Abnormalities Correlate to Biomarkers and Male Gender in Rheumatoid Arthritis Patients? A Monocentric Cross-Sectional StudyFrancesca Bandinelli, Maurizio Benucci, Ilenia Mallia, et al.
Current Rheumatology Reviews|July 2, 2016
A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory ArthritisValentina Grossi, Maria Infantino, Mariangela Manfredi, et al.
Clinical Chemistry and Laboratory Medicine|July 19, 2019
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experienceMaria Infantino, Francesca Pregnolato, Chelsea Bentow, et al.
Therapeutics and Clinical Risk Management|December 1, 2018
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variablesLaura Niccoli, Carlotta Nannini, Corrado Blandizzi, et al.
Rheumatology (Oxford, England)|April 5, 2018
Anti-DFS70 autoantibodies in undifferentiated connective tissue diseases subjects: what's on the horizon?Maria Infantino, Ora Shovman, Dolores Pérez, et al.
Immunological Investigations|August 13, 2019
Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead ImmunoassaysValentina Grossi, Maria Infantino, Maurizio Benucci, et al.
Immunologic Research|July 25, 2016
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational studyMaurizio Benucci, Francesca Li Gobbi, Francesca Bandinelli, et al.
Seminars in Arthritis and Rheumatism|April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Cytometry. Part B, Clinical Cytometry|January 22, 2017
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometersValentina Grossi, Maria Infantino, Francesca Meacci, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Antibodies (Basel, Switzerland)|March 24, 2026
Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel ObservationMaurizio Benucci, Elisa Cioffi, Francesca Li Gobbi, et al.
Journal of Clinical Medicine|June 27, 2024
Do Ultrasound Lung Abnormalities Correlate to Biomarkers and Male Gender in Rheumatoid Arthritis Patients? A Monocentric Cross-Sectional StudyFrancesca Bandinelli, Maurizio Benucci, Ilenia Mallia, et al.
Current Rheumatology Reviews|July 2, 2016
A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory ArthritisValentina Grossi, Maria Infantino, Mariangela Manfredi, et al.
Clinical Chemistry and Laboratory Medicine|July 19, 2019
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experienceMaria Infantino, Francesca Pregnolato, Chelsea Bentow, et al.
Therapeutics and Clinical Risk Management|December 1, 2018
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variablesLaura Niccoli, Carlotta Nannini, Corrado Blandizzi, et al.
Rheumatology (Oxford, England)|April 5, 2018
Anti-DFS70 autoantibodies in undifferentiated connective tissue diseases subjects: what's on the horizon?Maria Infantino, Ora Shovman, Dolores Pérez, et al.
Immunological Investigations|August 13, 2019
Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead ImmunoassaysValentina Grossi, Maria Infantino, Maurizio Benucci, et al.
Immunologic Research|July 25, 2016
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational studyMaurizio Benucci, Francesca Li Gobbi, Francesca Bandinelli, et al.
Seminars in Arthritis and Rheumatism|April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Cytometry. Part B, Clinical Cytometry|January 22, 2017
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometersValentina Grossi, Maria Infantino, Francesca Meacci, et al.
Pageof 7